{"version":"1.2.0","chapters":[{"startTime":0,"title":"Intro"},{"startTime":33.280000000000001,"title":"Begr\u00fc\u00dfung"},{"startTime":205.93600000000001,"title":"Inzidenzen"},{"startTime":620.26800000000003,"title":"Sterblichkeit"},{"startTime":1156.499,"title":"Altersverteilung"},{"startTime":1757.759,"title":"Bundesl\u00e4nder"},{"startTime":2054.5169999999998,"title":"Tests und Positivquote"},{"startTime":2241.982,"title":"Impfkampagne in Deutschland"},{"startTime":2940.125,"title":"Delta"},{"startTime":3383.348,"title":"Varianten international"},{"startTime":3548.2539999999999,"title":"Cubas Impfstoff"},{"startTime":3895.328,"title":"BioNTech Quartalsergebnisse"},{"startTime":4147.6099999999997,"title":"Zukunft der mRNA Technologie"},{"startTime":4771.3249999999998,"title":"10 Thesen zur Impfung"},{"startTime":5329.5360000000001,"title":"Wie geht es weiter?"},{"startTime":7587.9399999999996,"title":"Fazit"},{"startTime":7902.6639999999998,"title":"Bonus Track"}]}